We are live on ! Find out more
NVO

Novo Nordisk

1,049 hedge funds and large institutions have $19.3B invested in Novo Nordisk in 2022 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 296 increasing their positions, 353 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 206 | Existing positions closed: 49

77% more call options, than puts

Call options by funds: $252M | Put options by funds: $142M

64% more funds holding in top 10

Funds holding in top 10: 2846 (+18)

40% more capital invested

Capital invested by funds: $13.8B → $19.3B (+$5.48B)

16% more funds holding

Funds holding: 9071,049 (+142)

0.51% more ownership

Funds ownership: 15.94%16.45% (+0.51%)

16% less repeat investments, than reductions

Existing positions increased: 296 | Existing positions reduced: 353

Holders
1,049
Holders Change
+142
Holders Change %
+15.66%
% of All Funds
16.86%
Holding in Top 10
46
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+64.29%
% of All Funds
0.74%
New
206
Increased
296
Reduced
353
Closed
49
Calls
$252M
Puts
$142M
Net Calls
+$109M
Net Calls Change
+$51M
Name Holding Trade Value Shares
Change
Change in
Stake
IA
851
Integrity Advisory
Kansas
$224K +$194K +3,312 New
LNB
852
Ledyard National Bank
$223K +$193K +3,292 New
Mitsubishi UFJ Asset Management
853
Mitsubishi UFJ Asset Management
Japan
$222K -$17.6K -300 -8%
KLCM
854
KG&L Capital Management
Louisiana
$221K +$191K +3,266 New
DSN
855
D. Scott Neal
Kentucky
$220K +$191K +3,256 New
LWANC
856
Laurel Wealth Advisors (North Carolina)
North Carolina
$217K
CCM
857
Compton Capital Management
Rhode Island
$217K +$188K +3,200 New
GIA
858
Gladstone Institutional Advisory
Florida
$217K +$188K +3,206 New
WAM
859
WNY Asset Management
New York
$217K +$188K +3,200 New
FM
860
Family Management
New York
$216K +$187K +3,198 New
ERIM
861
Eagle Ridge Investment Management
Connecticut
$213K +$185K +3,150 New
9WM
862
9258 Wealth Management
Ohio
$213K -$247K -4,212 -57%
PAM
863
Palisade Asset Management
Minnesota
$212K +$184K +3,136 New
EWS
864
Evergreen Wealth Solutions
Pennsylvania
$210K +$182K +3,102 New
LIM
865
Lagoda Investment Management
New York
$208K -$83.8K -1,430 -32%
SBL
866
Sargent Bickham Lagudis
Colorado
$207K
MFS
867
McNamara Financial Services
Massachusetts
$207K +$179K +3,054 New
EIP
868
Ellis Investment Partners
Pennsylvania
$207K
AL
869
Aspiriant LLC
California
$205K +$177K +3,024 New
TAM
870
Tucker Asset Management
Colorado
$203K +$46.1K +786 +35%
JWCA
871
J.W. Cole Advisors
Florida
$203K +$176K +3,004 New
TCOO
872
Trust Company of Oklahoma
Oklahoma
$203K -$87.9K -1,500 -33%
BIA
873
Bigelow Investment Advisors
Maine
$203K +$176K +3,000 New
SIG
874
Sargent Investment Group
Maryland
$203K +$176K +3,000 New
HCMG
875
Howard Capital Management Group
California
$203K +$176K +3,000 New

NVO Hedge Fund Activity: Q4 2022 in Review

1,049 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2022, worth a combined $19.3B — up 40% from $13.8B a quarter earlier.

Buyers outnumbered sellers: 206 funds opened new NVO positions and 49 closed out — a net gain of 157 holders — while 296 added to existing stakes and 353 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $412M. The largest seller was Renaissance Technologies, cutting an estimated $317M.

  • 1,049 institutional investors held Novo Nordisk (NVO) as of Q4 2022, up from 907 in Q3 2022.
  • Funds reported $19.3B of Novo Nordisk stock for Q4 2022, up 40% quarter-over-quarter.
  • 206 funds opened new Novo Nordisk positions in Q4 2022 and 49 closed out, a net change of +157 holders.
  • The largest Novo Nordisk buyer in Q4 2022 was Fidelity Investments, an estimated $412M added.
  • The largest Novo Nordisk seller in Q4 2022 was Renaissance Technologies, an estimated $317M sold.

Based on aggregated 13F filings for Q4 2022.